Eight Republican Senators are pressing federal policymakers to justify why they backtracked on plans to ban certain products made from the kratom plant. Sen. Mike Crapo (R-Idaho) said he and his colleagues were calling upon the Food and Drug Administration and Drug Enforcement Administration (DEA) “to explain and reconsider proposed changes to the emergency scheduling order for semi-synthetic, kratom-derived substances.” Substances derived from the kratom plant are sold over the counter nationwide, “available to all age groups as ‘natural’ energy boosters, mood lifters and pain relievers,” Crapo wrote in a Nov. 18 statement. “According to the FDA, known side effects of kratom include liver toxicity, seizures, substance use disorder and, in rare cases, death,” he wrote. From 2021 to 2023, Idaho logged 47 deaths in which kratom was a contributing factor, a state report shows. The request, led by Senate Judiciary Committee Chairman Sen. Chuck Grassley (R-Iowa), Crapo, and six other Republicans, comes at a time of growing publicity over kratom-related deaths and addiction, along with controversy over kratom policymaking. Kratom advocates such as the American Kratom Association maintain that the natural kratom leaf is safe and even potentially beneficial. However, the FDA has said kratom is not approved for any use. The eight senators dispute advocates’ claims of safety. In their Nov. 16 letter to the FDA and DEA, they said: “We are not alone in our view that all Kratom is unsafe. This position is shared by physicians trained in addiction treatment and public health experts.” Potency Heightens Concerns The lawmakers are particularly concerned about concentrated, chemically modified versions of two major psychoactive components from kratom leaves: mitragynine and 7-hydroxymitragynine (7-OH). Earlier this year, the DEA announced that products containing more than 0.05 percent of 7-OH would be placed under Schedule I of the Controlled Substances Act. People who manufacture, distribute, sell, or possess Schedule I substances may be subject to fines, prosecution, or other penalties. Schedule I applies to substances with high potential for abuse and no accepted medical use. The American Kratom Association supported that proposed temporary ban, and said, “Do not ban kratom because of 7-OH. Ban 7-OH because it is not kratom.” The DEA also said it would include three semi-synthetic kratom-related substances, including mitragynine pseudoindoxyl (MP), in Schedule I. But last month, the DEA changed course. It decided to allow 7-OH and MP “to be present in over-the-counter kratom products at levels higher than those found naturally in the kratom plant,” the senators’ release said. The lawmakers asked the FDA to cite scientific and medical evaluations that support the revised DEA plan, “with an explanation why this new limit better protects the public.” The letter also asks the DEA, in consultation with the FDA, to revert to its previous, more restrictive order. On Oct. 30, several law enforcement groups—including the National Sheriffs Association and the Federal Law Enforcement Officers Association—urged the DEA to “permanently place the entire kratom plant and its preparations” on Schedule I. “A partial, threshold-based approach leaves dangerous products on store shelves and leaves those who must enforce the law, including prosecutors, law enforcement, and forensic laboratories, with a standard that is difficult to apply,” the groups wrote. Laws Lax But Lobbying ‘Unrelenting’ Although 12 states have fully banned kratom and four others strongly restrict it, most states “have done nothing,” according to End Kratom Addiction, an organization that Dean Francis of Virginia founded. He told The Epoch Times that people are slowly beginning to see “the amount of corruption or very questionable behavior within our federal agencies,” which he said predates the Trump administration. Francis said he hopes that “enough media attention could create that tipping point that would cause our U.S. lawmakers to engage and make our federal agencies do their jobs.” Francis said that kratom industry lobbying went “off-the-charts” just prior to the DEA’s policy pivot on kratom-related compounds. Calley Means, who recently left his job as a White House senior adviser, supported that claim. During a Nov. 6 interview with podcaster Joe Rogan, Means described “unrelenting lobbying” and “pushing from the [White House’s] West Wing” to relax standards on kratom-derived products. However, the Department of Health and Human Services (HHS)—which includes the FDA—released a statement to CBS’s “60 Minutes,” which aired Nov. 15, saying “neither political contributions nor outside pressure influenced our recommendation. Our responsibility is to protect Americans, and that is exactly what we did.” The Epoch Times sought comment from the FDA but received no reply before publication time. The DEA, in a Nov. 19 email to The Epoch Times, said it had received the GOP senators’ letter and “will respond accordingly.” Concerned Parents, Grassley Meet Francis met with Grassley on Nov. 18 on Capitol Hill along with three mothers who blame kratom products for their children’s deaths. Afterward, the four parents spoke to reporters. “I’m here today as a mother who lost Robert to kratom 58 days ago,” Rebecca Strang of Georgia said. Rebecca Strang said she is determined to find a purpose for her pain, “and for Robert’s life and legacy to be much larger than his death.” “The worst day of my life has suddenly become my life’s work,” she said. Lawmakers who are considering what to do about kratom need to understand “these are not just simply policy discussions,” she said. “They represent real people, real families, and real lives like Robert that are being tragically lost.” Strang called for all kratom products to be banned and said, “We have to stop putting profit and industry interests ahead of people’s lives.” Group Responds The American Kratom Association, in its news release responding to Grassley’s press event, expressed compassion for Strang and the other grieving mothers while questioning whether the deaths could truly be blamed on kratom. “In each of the cases of the mothers who participated with Sen. Grassley in his event, we know there are significant, legitimate questions that have now been raised about the role, if any, that kratom played in the death,” the group’s spokesman, Mac Haddow, said in a news release. The association also said it “recognizes the serious risks posed by chemically manipulated products containing 7-OH,” and other laboratory-manipulated compounds. The association also said it “strongly supports Connor’s End Gas Station Heroin Act (S. 5383 and H.R. 10272), which would remove these products from the marketplace, and the Kratom Consumer Protection Act, which sets age restrictions, labeling, and testing standards for natural kratom.”